{
  "trial_id": "NCT00633594",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, prior therapy, platelet count, absolute neutrophil count (ANC), creatinine clearance, total bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), presence of measurable lymph node or mass, history of thrombolic or embolic events, history of pulmonary hemorrhage, history of other hemorrhage events, history of brain metastasis, history of central nervous system involvement, history of second malignancy, history of hypersensitivity to study drugs, HIV status, hepatitis status, history of serious infection, history of bleeding diathesis or coagulopathy, history of major surgery, gastrointestinal function, cardiac history, blood pressure, prior use of lenalidomide.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "gender"
        ],
        [
          "Previous Treatment for Mantle Cell Lymphoma (MCL)",
          "prior therapy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Gender",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "ECOG performance status",
        "platelet count",
        "absolute neutrophil count (ANC)",
        "creatinine clearance",
        "total bilirubin",
        "aspartate transaminase (AST)",
        "alanine transaminase (ALT)",
        "presence of measurable lymph node or mass",
        "history of thrombolic or embolic events",
        "history of pulmonary hemorrhage",
        "history of other hemorrhage events",
        "history of brain metastasis",
        "history of central nervous system involvement",
        "history of second malignancy",
        "history of hypersensitivity to study drugs",
        "HIV status",
        "hepatitis status",
        "history of serious infection",
        "history of bleeding diathesis or coagulopathy",
        "history of major surgery",
        "gastrointestinal function",
        "cardiac history",
        "blood pressure",
        "prior use of lenalidomide"
      ]
    },
    "processed-gen-response": "Age, gender, race, ECOG performance status, prior therapy, platelet count, absolute neutrophil count (ANC), creatinine clearance, total bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), presence of measurable lymph node or mass, history of thrombolic or embolic events, history of pulmonary hemorrhage, history of other hemorrhage events, history of brain metastasis, history of central nervous system involvement, history of second malignancy, history of hypersensitivity to study drugs, HIV status, hepatitis status, history of serious infection, history of bleeding diathesis or coagulopathy, history of major surgery, gastrointestinal function, cardiac history, blood pressure, prior use of lenalidomide."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Platelet Count, Absolute Neutrophil Count (ANC), Creatinine Clearance, Total Bilirubin, Aspartate Transaminase (AST), Alanine Transaminase (ALT), Prior Therapy, Lymph Node Size,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Previous Treatment for Mantle Cell Lymphoma (MCL)",
          "Prior Therapy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Gender"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Platelet Count",
        "Absolute Neutrophil Count (ANC)",
        "Creatinine Clearance",
        "Total Bilirubin",
        "Aspartate Transaminase (AST)",
        "Alanine Transaminase (ALT)",
        "Lymph Node Size"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Platelet Count, Absolute Neutrophil Count (ANC), Creatinine Clearance, Total Bilirubin, Aspartate Transaminase (AST), Alanine Transaminase (ALT), Prior Therapy, Lymph Node Size"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Prior Therapy, Platelet Count, Absolute Neutrophil Count, Creatinine Clearance, Total Bilirubin, AST, ALT, Peripheral Neuropathy, History of Thrombolic or Embolic Events, History of Pulmonary Hemorrhage/Bleeding Event, History of Brain Metastasis, History of CNS Involvement by Lymphoma, History of Second Malignancy, History of HIV Infection or Chronic Hepatitis, History of Bleeding Diathesis or Coagulopathy, History of Major Surgery/Open Biopsy/Significant Traumatic Injury, History of Cardiac Problems.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Previous Treatment for Mantle Cell Lymphoma (MCL)",
          "Prior Therapy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Gender"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Platelet Count",
        "Absolute Neutrophil Count",
        "Creatinine Clearance",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Peripheral Neuropathy",
        "History of Thrombolic or Embolic Events",
        "History of Pulmonary Hemorrhage/Bleeding Event",
        "History of Brain Metastasis",
        "History of CNS Involvement by Lymphoma",
        "History of Second Malignancy",
        "History of HIV Infection or Chronic Hepatitis",
        "History of Bleeding Diathesis or Coagulopathy",
        "History of Major Surgery/Open Biopsy/Significant Traumatic Injury",
        "History of Cardiac Problems"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Prior Therapy, Platelet Count, Absolute Neutrophil Count, Creatinine Clearance, Total Bilirubin, AST, ALT, Peripheral Neuropathy, History of Thrombolic or Embolic Events, History of Pulmonary Hemorrhage/Bleeding Event, History of Brain Metastasis, History of CNS Involvement by Lymphoma, History of Second Malignancy, History of HIV Infection or Chronic Hepatitis, History of Bleeding Diathesis or Coagulopathy, History of Major Surgery/Open Biopsy/Significant Traumatic Injury, History of Cardiac Problems."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, histology, prior therapy, presence of lymph node evaluable or mass measurable for response, platelet count, absolute neutrophil count, renal function, total bilirubin, aspartate transaminase, alanine transaminase.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Previous Treatment for Mantle Cell Lymphoma (MCL)",
          "prior therapy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Gender",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "ECOG performance status",
        "histology",
        "presence of lymph node evaluable or mass measurable for response",
        "platelet count",
        "absolute neutrophil count",
        "renal function",
        "total bilirubin",
        "aspartate transaminase",
        "alanine transaminase"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, histology, prior therapy, presence of lymph node evaluable or mass measurable for response, platelet count, absolute neutrophil count, renal function, total bilirubin, aspartate transaminase, alanine transaminase."
  }
}